中性鞘磷脂酶介导酒精滥用、重性抑郁与骨缺陷的共病三联征
在酒精依赖患者中观察到血清中性鞘磷脂酶活性升高;对456,693名志愿者的遗传关联分析发现,编码NSM-2的中性鞘磷脂酶(SMPD3)单倍型与饮酒量、情感状态及骨矿化相关。小鼠功能分析显示NSM通过调节海马体积、皮层连接和单胺能反应控制饮酒、情感行为及其交互,并通过增强骨钙素信号调控骨-脑交流。
要点
- 酒精依赖患者血清中性鞘磷脂酶活性升高。
- SMPD3单倍型与饮酒、情感状态及骨矿化相关。
- NSM通过骨钙素信号调控骨-脑交流,影响饮酒和抑郁行为。
核心结论
- 单个基因NSM是连接酒精滥用、抑郁/焦虑和骨 disorder 的脑与骨多通路来源。
- 靶向NSM和骨钙素信号可能为精神-躯体共病三联征提供新的系统治疗思路。
研究设计与样本
- 在酒精依赖患者中检测血清中性鞘磷脂酶活性。
- 对456,693名志愿者进行遗传关联分析,检验SMPD3单倍型与饮酒、情感状态及骨矿化的关联。
- 在小鼠中进行功能分析,研究NSM对饮酒、情感行为及其交互的调控。
主要发现
- 酒精依赖患者血清中性鞘磷脂酶活性升高。
- 456,693名志愿者中,编码NSM-2的SMPD3单倍型与饮酒量、情感状态及骨矿化相关。
- 小鼠中NSM通过调节海马体积、皮层连接和单胺能反应控制饮酒、情感行为及其交互。
- NSM通过增强骨钙素信号控制骨-脑交流,骨钙素信号可独立抑制饮酒并减少抑郁行为。
临床怎么用
- NSM和骨钙素信号可能成为治疗酒精滥用-抑郁/焦虑-骨 disorder 共病三联征的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mental disorders are highly comorbid and occur together with physical diseases, which are often considered to arise from separate pathogenic pathways. We observed in alcohol-dependent patients increased serum activity of neutral sphingomyelinase. A genetic association analysis in 456,693 volunteers found associations of haplotypes of SMPD3 coding for NSM-2 (NSM) with alcohol consumption, but also with affective state, and bone mineralisation. Functional analysis in mice showed that NSM controls alcohol consumption, affective behaviour, and their interaction by regulating hippocampal volume, cortical connectivity, and monoaminergic responses. Furthermore, NSM controlled bone-brain communication by enhancing osteocalcin signalling, which can independently supress alcohol consumption and reduce depressive behaviour. Altogether, we identified a single gene source for multiple pathways originating in the brain and bone, which interlink disorders of a mental-physical co-morbidity trias of alcohol abuse-depression/anxiety-bone disorder. Targeting NSM and osteocalcin signalling may, thus, provide a new systems approach in the treatment of a mental-physical co-morbidity trias.
引用
- Kalinichenko LS, Mühle C, Jia T, et al. Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects. Mol Psychiatry. 2021. PMID: 34584229. doi:10.1038/s41380-021-01304-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。